Location: Home
  • search
  • go
  • Relate News
  • 12/23/2013New Reports Predict Rising Consumption of Diabetes Drugs and Insulin i...
  • 12/21/2013BMS Sells Global Diabetes Business to AstraZeneca Pending Antitrust an...
  • 11/29/2013New Report: Chinese Diabetes Drug Market to See Substantial Growth thr...
  • 11/20/2013Diabetes Prevalence Rises Faster in Rural Areas
  • 11/20/2013India to Launch New Measure to Restrict Foreign Investment in Pharma I...
  • 11/18/2013Eli Lilly Invests US$350M to Expand Its Insulin Cartridge Production C...
  • 10/24/2013Salubris Pharma Licenses China Rights of Fotagliptin from Fosun
  • 10/22/2013Chinese Smuggling of Low Cost Indian Cancer Medicines Gains Momentum
  • 10/21/2013Fosun Subsidiary Outlicenses Two Diabetes Drug Candidates to Sellas
  • 9/17/2013Escalating Diabetes Prevalence Threatens to Bankrupt China
  • 9/4/2013China Warned of A Major Epidemic of Diabetes-related Complications
  • 8/8/2013China's Type II Diabetes Drug Market to Grow 10% CAGR by 2017
  • 8/7/2013ScinoPharm Forms Strategic Alliance with Sundia MediTech for CRAMS
  • 8/6/2013India Partially Revokes Patent of Roche's Herceptin
  • 7/31/2013Takeda Gets CFDA Approval for Import of Diabetes Drug Nesina
  • 7/2/2013China Maintains Antidumping Duties on SMZ from India
  • 6/17/2013Chinese Diabetes Drug Market to Maintain Double-digit Growth by 2017
  • 4/24/2013Takeda Lines Up with Sanofi to Co-promote Its Diabetes Drug Alogliptin
  • 4/21/2013Bayer's Star Contraceptive Diane-35 under EMA Investigation
  • 4/12/2013AZ and BMS to Co-market BYETTA in China
  • 4/2/2013Novartis Loses Landmark Patent Case for Glivec
  • 3/19/2013BMS to Launch At Least Four More Diabetes Drugs in China by 2015
  • 3/19/2013Merck KGaA, BMS Join Hands for Co-promotion of Glucophage in China
  • 3/1/2013Ipsos: Most Type 2 Diabetes Patients in China Yet to Benefit from Newe...
  • 2/1/2013Pharmaceutical Company Loses CNY 1 Billion after 140-word Weibo Messag...
  • 1/30/2013Merck Launches Janumet in China
  • 1/25/2013New Report: Chinese Diabetes Drug Market Dominated by Insulin Products
  • 12/26/2012Are East Asians More at Risk for Type-2 Diabetes?
  • 12/19/2012India Imports Most APIs from China
  • 11/30/2012Government Seeks to Boost Pediatric Drugs with More Incentive Policies
  • Page:10/16 Total number of articles:474: [First][<<] [8] [9] [10] [11] [12] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group